phenylbutazone has been researched along with Ornithine Carbamoyltransferase Deficiency Disease in 3 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ornithine transcarbamylase deficiency is the most common inherited urea cycle disorder." | 6.43 | [Hyperammonemia type II as an example of urea cycle disorder]. ( Duława, J; Hawrot-Kawecka, AM; Kawecki, GP, 2006) |
| "Ornithine transcarbamylase deficiency is the most common inherited urea cycle disorder." | 2.43 | [Hyperammonemia type II as an example of urea cycle disorder]. ( Duława, J; Hawrot-Kawecka, AM; Kawecki, GP, 2006) |
| "The symptoms and signs of ornithine transcarbamylase deficiency are discussed." | 2.42 | Ornithine transcarbamylase deficiency: a urea cycle defect. ( Gordon, N, 2003) |
| "X-linked inherited ornithine transcarbamylase deficiency is the most frequent urea cycle disorder." | 1.31 | Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations. ( Garrigue, MA; Kouatchet, A; Labarthe, F; Legras, A; Maillot, F; Ogier de Baulny, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, N | 1 |
| Hawrot-Kawecka, AM | 1 |
| Kawecki, GP | 1 |
| Duława, J | 1 |
| Legras, A | 1 |
| Labarthe, F | 1 |
| Maillot, F | 1 |
| Garrigue, MA | 1 |
| Kouatchet, A | 1 |
| Ogier de Baulny, H | 1 |
2 reviews available for phenylbutazone and Ornithine Carbamoyltransferase Deficiency Disease
| Article | Year |
|---|---|
Ornithine transcarbamylase deficiency: a urea cycle defect.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Food Preservatives; Humans; Hyperammonemia; Infant, Newborn | 2003 |
[Hyperammonemia type II as an example of urea cycle disorder].
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Coma; Female; Humans; Hyperammonemi | 2006 |
1 other study available for phenylbutazone and Ornithine Carbamoyltransferase Deficiency Disease
| Article | Year |
|---|---|
Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations.
Topics: Adult; Coma; Female; Hemofiltration; Humans; Hyperammonemia; Middle Aged; Ornithine Carbamoyltransfe | 2002 |